M1 Kliniken AG: Management Board confirms growth targets

EQS-News: M1 Kliniken AG / Key word(s): Forecast
M1 Kliniken AG: Management Board confirms growth targets

21.06.2024 / 12:47 CET/CEST
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

M1 Kliniken AG: Management Board confirms growth targets

Berlin, 21 June 2024 - As announced on 20 June 2024, Management Board member
Attila Strauss has sold part of his stake in M1 Kliniken AG (ISIN:
DE000A0STSQ8) for personal financial reasons. Mr Strauss continues to hold a
tangible stake of over 2.3% in M1 Kliniken AG.

Attila Strauss emphasises: "I understand that such sales can lead to
uncertainty and want to assure you that my commitment and belief in the
company and the investment is unwavering and long term. I firmly believe
that M1 Med Beauty has excellent growth opportunities in the global beauty
market. Our latest business figures and forecasts remain strong, with
planned sales growth of up to 30% and an increase in EBIT of up to 40% in
2024. Our strategy and strong market position give me great confidence in
the future. Together with our dedicated team, we will continue to work on
developing M1 Med Beauty into the world's leading private provider of beauty
treatments."

The Group's medium-term forecast envisages that M1 will operate a total of
150 to 200 specialist medical centres for aesthetic medicine by the end of
2029. The Beauty segment should thus generate revenue of between EUR 200 and
300 million with an EBIT margin of at least 20 %. To put this into
perspective: in 2023, the Beauty segment generated revenue of around EUR
70.8 million with 58 locations.

About M1 Kliniken AG

M1 Kliniken AG is the leading fully integrated provider of aesthetic medical
healthcare services in Europe. The Group offers products and services of the
highest quality standards in the aesthetic and surgical fields. Beauty
medical treatments are currently offered at 62 specialist centres under the
"M1 Med Beauty" brand. With six operating rooms and 35 beds, the "M1
Schlossklinik" for Plastic and Aesthetic Surgery in Berlin is one of the
largest and most modern facilities of its kind in Europe. M1 Kliniken has
been driving forward its internationalisation since the end of 2018 and is
currently represented in ten countries.

Contact:
M1 Kliniken AG
Grünauer Straße 5
12557 Berlin
T: +49 (0)30 347 47 44 14
M: ir@m1-kliniken.de


---------------------------------------------------------------------------

21.06.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS
News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

---------------------------------------------------------------------------

   Language:       English
   Company:        M1 Kliniken AG
                   Grünauer Straße 5
                   12557 Berlin
                   Germany
   Phone:          +49 (0)30 347 47 44 14
   Fax:            +49 (0)30 347 47 44 17
   E-mail:         ir@m1-kliniken.de
   Internet:       https://www.m1-kliniken.de
   ISIN:           DE000A0STSQ8
   WKN:            A0STSQ
   Listed:         Regulated Unofficial Market in Berlin, Dusseldorf,
                   Frankfurt (Basic Board), Hamburg, Hanover, Munich,
                   Stuttgart, Tradegate Exchange
   EQS News ID:    1930795

End of News EQS News Service
---------------------------------------------------------------------------

1930795 21.06.2024 CET/CEST